Opening Bell Analysts Research Calls for Thursday, February 2
This report was sent to Briefing.com subscribers earlier today. Research calls posted earlier this morning are available here. Upgrades: > Align Tech (ALGN) upgraded to Neutral from Sell at Goldman; tgt raised to $307 > Graco (GGG) upgraded to Buy…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Align Tech (ALGN) upgraded to Neutral from Sell at Goldman; tgt raised to $307
> Graco (GGG) upgraded to Buy from Neutral at Seaport Research Partners; tgt $82
> McGrath RentCorp (MGRC) upgraded to Buy from Neutral at Sidoti; tgt $127
> Meta Platforms (META) upgraded to Buy from Neutral at BofA Securities; tgt raised to $220
> Meta Platforms (META) upgraded to Buy from Neutral at Rosenblatt; tgt raised to $220
> Meta Platforms (META) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $215
> TC Energy (TRP) upgraded to Sector Outperform from Neutral at CIBC
Downgrades:
> First Solar (FSLR) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $195
> Fortune Brands Innovations (FBIN) downgraded to Hold from Buy at Loop Capital; tgt $65
> Hugo Boss AG (BOSSY) downgraded to Hold from Buy at Jefferies
> Sysco (SYY) downgraded to Hold from Buy at Argus
Others:
> 10x Genomics (TXG) initiated with a Neutral at UBS; tgt $50
> Akoya Biosciences (AKYA) initiated with a Buy at UBS; tgt $14
> Darden Restaurants (DRI) initiated with a Buy at Guggenheim; tgt $170
> MoonLake Immunotherapeutics (MLTX) initiated with a Buy at Bryan Garnier; tgt $22
> NanoString Technologies (NSTG) initiated with a Buy at UBS; tgt $15
> Pacific Biosciences (PACB) initiated with a Neutral at UBS; tgt $13
Contact [email protected] for any questions or corrections.